These outcomes were presented at the 2009 2009 American Heart Associations Scientific Classes.

Abbott Announces Positive Three-Year Data on It is Fully Bioabsorbable Stent Technology Abbott today announced three-season data from the first 30 patients in the first phase of the ABSORB clinical trial, demonstrating that its fully bioabsorbable drug eluting coronary stent successfully treated coronary artery disease and was absorbed into the walls of treated arteries. Sufferers in this first phase of the ABSORB trial experienced no stent thrombosis out to three years and no new main adverse cardiac events ) between half a year and three years . These outcomes were presented at the 2009 2009 American Heart Association’s Scientific Classes.Kaiser Health Information, an unbiased news service editorially, is a program of the Kaiser Family members Foundation, a nonpartisan healthcare policy research corporation unaffiliated with Kaiser Permanente.. Allina Hospitals selects Acuo Systems’ integrated medical imaging answer for improved patient care Acuo Technologies, programmers of high-performance medical picture management software, data migration services and tools, today announced contracting with Allina Hospitals and Clinics for a fresh Vendor Neutral Archive , providing the building blocks of image storage across the Allina network of hospitals, affiliates and clinics.